Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Policy

Business Urges Action On Russia Trade Bill

by Glenn Hess
October 1, 2012 | A version of this story appeared in Volume 90, Issue 40

A broad-based business coalition that includes some of the largest chemical and pharmaceutical companies in the U.S. is calling on Congress to lift Cold War-era trade sanctions and normalize trade relations with Russia. The Coalition for U.S.-Russia Trade says the action is necessary so that U.S. businesses can reap the benefits of Russia’s recent accession to the World Trade Organization, including lower tariffs for American-made products. “We strongly urge the White House and Congress to work together to ensure passage of this legislation as quickly as possible after the November elections,” the coalition said in a Sept. 21 letter to congressional leaders and President Barack Obama. Coalition members include Dow Chemical, DuPont, Eli Lilly & Co., and Pfizer. Pending legislation (H.R. 6156) would grant Russia “permanent normal trade relations” by removing a 1974 trade provision called the Jackson-Vanik amendment. Action on the bill has been repeatedly delayed this year because of concern over Moscow’s record on human rights. “This is an opportunity for Congress to act on a bipartisan bill to help boost exports and create jobs,” says Linda Dempsey, vice president of international economic affairs for the National Association of Manufacturers.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.